Mechanistically, we showed that the SARS‐CoV‐2 spike protein, guided by the mRNA COVID‐19 vaccine, interferes with insulin signaling by binding to angiotensin‐converting enzyme 2, TLR4, and ER. The gene discussed is TLR4; the disease is COVID-19.